XML 57 R41.htm IDEA: XBRL DOCUMENT v3.22.4
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]  
Summary of Error Correction Adjustments
CONDENSED CONSOLIDATED BALANCE SHEET
(in thousands, except share and per share data)
(Unaudited)
September 30, 2022
As ReportedAdjustmentAs Restated
ASSETS
Current assets:
 Cash and cash equivalents$166,256 $— $166,256 
Accounts receivable, net85,612 — 85,612 
Inventories120,467 — 120,467 
Income tax receivable655 — 655 
Prepaid expenses and other current assets4,876 — 4,876 
Total current assets377,866 — 377,866 
Property, plant and equipment, net57,187 — 57,187 
Goodwill1,019,387 — 1,019,387 
Customer lists, net715,829 — 715,829 
Technology and patents, net233,861 — 233,861 
Tradenames, net95,047 — 95,047 
Other assets, net1,877 — 1,877 
Total assets$2,501,054 $— $2,501,054 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable$31,856 $— $31,856 
Accrued expenses and other current liabilities124,429 (65,401)59,028 
Founders advisory fees payable - related party9,836 — 9,836 
Deferred revenue1,272 — 1,272 
Total current liabilities167,393 (65,401)101,992 
Long-term debt664,986 — 664,986 
Deferred income taxes222,952 50,467 273,419 
Founders advisory fees payable - related party134,598 — 134,598 
Redeemable preferred shares100,263 — 100,263 
Redeemable preferred shares - related party3,245 — 3,245 
Other non-current liabilities8,951 — 8,951 
Total liabilities1,302,388 (14,934)1,287,454 
Commitments and contingencies
Shareholders’ equity:
Ordinary shares, $1 nominal value per share, 4,000,000,000 shares authorized; 163,234,542 shares issued; 162,316,326 shares outstanding
163,235 — 163,235 
Treasury shares, at cost; 918,216 shares
(7,572)— (7,572)
Additional paid-in capital1,697,644 (11,746)1,685,898 
Accumulated other comprehensive loss(41,561)— (41,561)
Accumulated deficit(613,080)26,680 (586,400)
Total shareholders’ equity1,198,666 14,934 1,213,600 
Total liabilities and shareholders’ equity$2,501,054 $— $2,501,054 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME (LOSS)
(in thousands, except share and per share data)
(Unaudited)

Three Months Ended September 30, 2022Nine Months Ended September 30, 2022
As ReportedAdjustmentAs RestatedAs ReportedAdjustmentAs Restated
Net sales$160,509 $— $160,509 $319,232 $— $319,232 
Cost of goods sold74,707 (946)73,761 191,757 (4,603)187,154 
Gross profit85,802 946 86,748 127,475 4,603 132,078 
Operating expenses:
Selling, general and administrative expense22,381 (6,731)15,650 64,803 (10,320)54,483 
Amortization expense13,738 — 13,738 41,395 — 41,395 
Founders advisory fees - related party(73,713)— (73,713)(154,026)— (154,026)
Other operating expense(51)— (51)405 — 405 
Total operating expenses(37,645)(6,731)(44,376)(47,423)(10,320)(57,743)
Operating income123,447 7,677 131,124 174,898 14,923 189,821 
Other expense (income):
Interest expense, net9,944 — 9,944 32,582 — 32,582 
Gain on contingent earn-out(3,644)— (3,644)(13,042)— (13,042)
Unrealized foreign currency loss4,705 — 4,705 8,741 — 8,741 
Other income, net(785)— (785)(820)— (820)
Total other expense, net10,220 — 10,220 27,461 — 27,461 
Income before income taxes113,227 7,677 120,904 147,437 14,923 162,360 
Income tax (expense) benefit(34,516)19,839 (14,677)(23,692)13,449 (10,243)
Net income78,711 27,516 106,227 123,745 28,372 152,117 
Other comprehensive loss, net of tax:
Foreign currency translation adjustments(18,181)— (18,181)(34,426)— (34,426)
Total comprehensive income$60,530 $27,516 $88,046 $89,319 $28,372 $117,691 
Earnings per share:
Basic$0.48 $0.17 $0.65 $0.76 $0.18 $0.94 
Diluted$0.45 $0.15 $0.60 $0.70 $0.16 $0.86 
Weighted average number of ordinary shares outstanding:
Basic162,635,592 — 162,635,592 161,943,492 — 161,943,492 
Diluted176,777,958 — 176,777,958 176,085,858 — 176,085,858 
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY
(in thousands, except share data)
(Unaudited)

Ordinary SharesTreasury SharesAdditional
Paid-in
Capital
Accumulated
Other
Comprehensive
Loss
Accumulated
Deficit
Total
Shareholders'
Equity
SharesAmountSharesAmount
As Reported
Balance, June 30, 2022163,234,542 $163,235 597,513 $(5,008)$1,690,812 $(23,380)$(691,791)$1,133,868 
Share-based compensation— — — — 6,832 — — 6,832 
Ordinary shares repurchased— — 320,703 (2,564)— — — (2,564)
Net income— — — — — — 78,711 78,711 
Other comprehensive loss— — — — — (18,181)— (18,181)
Balance, September 30, 2022163,234,542 $163,235 918,216 $(7,572)$1,697,644 $(41,561)$(613,080)$1,198,666 
Adjustments
Balance, June 30, 2022— $— — $— $(4,069)$— $(836)$(4,905)
Share-based compensation— — — — (7,677)— — (7,677)
Net income— — — — — — 27,516 27,516 
Total Adjustments— $— — $— $(11,746)$— $26,680 $14,934 
As Restated
Balance, June 30, 2022163,234,542 $163,235 597,513 $(5,008)$1,686,743 $(23,380)$(692,627)$1,128,963 
Share-based compensation— — — — (845)— — (845)
Ordinary shares repurchased— — 320,703 (2,564)— — — (2,564)
Net income— — — — — — 106,227 106,227 
Other comprehensive loss— — — — — (18,181)— (18,181)
Balance, September 30, 2022163,234,542 $163,235 918,216 $(7,572)$1,685,898 $(41,561)$(586,400)$1,213,600 
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(in thousands)
(Unaudited)
Nine Months Ended September 30, 2022
As ReportedAdjustmentAs Restated
Cash flows from operating activities:
Net income$123,745 $28,372 $152,117 
Adjustments to reconcile net income to net cash used in operating activities:
Founders advisory fees - related party (change in accounting fair value)(154,026)— (154,026)
Depreciation and amortization expense49,536 — 49,536 
Interest and payment-in-kind on preferred shares4,903 — 4,903 
Share-based compensation19,297 (11,746)7,551 
Deferred income taxes(72,441)51,953 (20,488)
Amortization of deferred financing costs1,196 — 1,196 
Amortization of acquisition related inventory step-up27,973 (3,177)24,796 
Gain on contingent earn-out(13,042)— (13,042)
Unrealized loss on foreign currency8,741 — 8,741 
Loss on disposal of assets— 
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable(63,838)— (63,838)
Inventories(40,759)— (40,759)
Prepaid expenses and other current assets9,058 — 9,058 
Accounts payable4,975 — 4,975 
Deferred revenue889 — 889 
Income taxes payable, net88,673 (65,402)23,271 
Accrued expenses and other current liabilities15,547 — 15,547 
Founders advisory fees - related party (cash settled)(53,547)— (53,547)
Other liabilities(73)— (73)
Net cash used in operating activities(43,184)— (43,184)
Cash flows from investing activities:
Purchase of property and equipment(6,024)— (6,024)
Purchase price adjustment under Business Combination Agreement(1,638)— (1,638)
Net cash used in investing activities(7,662)— (7,662)
Cash flows from financing activities:
Ordinary shares repurchased(7,572)— (7,572)
Proceeds from exercise of warrants529 529 
Net cash used in financing activities(7,043)— (7,043)
Effect of foreign currency on cash and cash equivalents(1,409)— (1,409)
Net change in cash and cash equivalents(59,298)— (59,298)
Cash and cash equivalents, beginning of period225,554 — 225,554 
Cash and cash equivalents, end of period$166,256 $— $166,256 
Supplemental disclosures of cash flow information:
Cash paid for interest$18,299 $— $18,299 
Cash paid for income taxes$7,588 $— $7,588 
Non-cash investing and financing activities:
Liability portion of founders advisory fees - related party reclassified to additional paid in capital$13,783 $— $13,783 
CONDENSED CONSOLIDATED BALANCE SHEET
(in thousands, except share and per share data)
(Unaudited)
June 30, 2022
As ReportedAdjustmentAs Restated
ASSETS
Current assets:
 Cash and cash equivalents$125,502 $— $125,502 
Accounts receivable, net68,458 — 68,458 
Inventories123,065 — 123,065 
Income tax receivable25,608 (14,167)11,441 
Prepaid expenses and other current assets6,763 — 6,763 
Total current assets349,396 (14,167)335,229 
Property, plant and equipment, net59,155 — 59,155 
Goodwill1,031,219 — 1,031,219 
Customer lists, net730,339 — 730,339 
Technology and patents, net239,043 — 239,043 
Tradenames, net96,960 — 96,960 
Other assets, net1,992 — 1,992 
Total assets$2,508,104 $(14,167)$2,493,937 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable$42,967 $— $42,967 
Accrued expenses and other current liabilities22,876 — 22,876 
Founders advisory fees payable - related party27,116 — 27,116 
Deferred revenue5,387 — 5,387 
Total current liabilities98,346 — 98,346 
Long-term debt664,696 — 664,696 
Deferred income taxes304,993 (9,262)295,731 
Founders advisory fees payable - related party191,031 — 191,031 
Redeemable preferred shares99,312 — 99,312 
Redeemable preferred shares - related party3,215 — 3,215 
Other non-current liabilities12,643 — 12,643 
Total liabilities1,374,236 (9,262)1,364,974 
Commitments and contingencies
Shareholders’ equity:
Ordinary shares, $1 nominal value per share, 4,000,000,000 shares authorized; 163,234,542 shares issued; 162,637,029 shares outstanding
163,235 — 163,235 
Treasury shares, at cost; 597,513 shares
(5,008)— (5,008)
Additional paid-in capital1,690,812 (4,069)1,686,743 
Accumulated other comprehensive loss(23,380)— (23,380)
Accumulated deficit(691,791)(836)(692,627)
Total shareholders’ equity1,133,868 (4,905)1,128,963 
Total liabilities and shareholders’ equity$2,508,104 $(14,167)$2,493,937 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME (LOSS)
(in thousands, except share and per share data)
(Unaudited)

Three Months Ended June 30, 2022Six Months Ended June 30, 2022
As ReportedAdjustmentAs RestatedAs ReportedAdjustmentAs Restated
Net sales$100,965 $— $100,965 $158,723 $— $158,723 
Cost of goods sold72,423 (373)72,050 117,050 (3,657)113,393 
Gross profit28,542 373 28,915 41,673 3,657 45,330 
Operating expenses:
Selling, general and administrative expense22,614 (2,935)19,679 42,422 (3,589)38,833 
Amortization expense13,802 — 13,802 27,657 — 27,657 
Founders advisory fees - related party(20,465)— (20,465)(80,313)— (80,313)
Other operating expense260 — 260 456 — 456 
Total operating expenses16,211 (2,935)13,276 (9,778)(3,589)(13,367)
Operating income12,331 3,308 15,639 51,451 7,246 58,697 
Other expense (income):
Interest expense, net12,142 — 12,142 22,638 — 22,638 
Gain on contingent earn-out(9,398)— (9,398)(9,398)— (9,398)
Unrealized foreign currency loss3,156 — 3,156 4,036 — 4,036 
Other income, net(200)— (200)(35)— (35)
Total other expense, net5,700 — 5,700 17,241 — 17,241 
Income before income taxes6,631 3,308 9,939 34,210 7,246 41,456 
Income tax benefit (expense)592 (1,604)(1,012)10,824 (6,390)4,434 
Net income7,223 1,704 8,927 45,034 856 45,890 
Other comprehensive loss, net of tax:
Foreign currency translation adjustments(16,371)— (16,371)(16,245)— (16,245)
Total comprehensive (loss) income$(9,148)$1,704 $(7,444)$28,789 $856 $29,645 
Earnings per share:
Basic$0.04 $0.01 $0.05 $0.28 $— $0.28 
Diluted$0.04 $0.01 $0.05 $0.26 $— $0.26 
Weighted average number of ordinary shares outstanding:
Basic162,917,478 — 162,917,478 161,591,704 — 161,591,704 
Diluted177,059,844 — 177,059,844 175,734,070 — 175,734,070 
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY
(in thousands, except share data)
(Unaudited)

Ordinary SharesTreasury SharesAdditional
Paid-in
Capital
Accumulated
Other
Comprehensive
Loss
Accumulated
Deficit
Total
Shareholders'
Equity
SharesAmountSharesAmount
As Reported
Balance, March 31, 2022163,234,542 $163,235 — $— $1,684,071 $(7,009)$(699,014)$1,141,283 
Share-based compensation— — — — 6,741 — — 6,741 
Ordinary shares repurchased— — 597,513 (5,008)— — — (5,008)
Net income— — — — — — 7,223 7,223 
Other comprehensive loss— — — — — (16,371)— (16,371)
Balance, June 30, 2022163,234,542 $163,235 597,513 $(5,008)$1,690,812 $(23,380)$(691,791)$1,133,868 
Adjustments
Balance, March 31, 2022— $— — $— $(761)$— $(2,540)$(3,301)
Share-based compensation— — — — (3,308)— — (3,308)
Net income— — — — — — 1,704 1,704 
Total Adjustments— $— — $— $(4,069)$— $(836)$(4,905)
As Restated
Balance, March 31, 2022163,234,542 $163,235 — $— $1,683,310 $(7,009)$(701,554)$1,137,982 
Share-based compensation— — — — 3,433 — — 3,433 
Ordinary shares repurchased— — 597,513 (5,008)— — — (5,008)
Net income— — — — — — 8,927 8,927 
Other comprehensive loss— — — — — (16,371)— (16,371)
Balance, June 30, 2022163,234,542 $163,235 597,513 $(5,008)$1,686,743 $(23,380)$(692,627)$1,128,963 
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(in thousands)
(Unaudited)
Six Months Ended June 30, 2022
As ReportedAdjustmentAs Restated
Cash flows from operating activities:
Net income$45,034 $856 $45,890 
Adjustments to reconcile net income to net cash used in operating activities:
Founders advisory fees - related party (change in accounting fair value)(80,313)— (80,313)
Depreciation and amortization expense33,086 — 33,086 
Interest and payment-in-kind on preferred shares3,268 — 3,268 
Share-based compensation12,465 (4,069)8,396 
Deferred income taxes7,648 (7,777)(129)
Amortization of deferred financing costs793 — 793 
Amortization of acquisition related inventory step-up27,315 (3,177)24,138 
Gain on contingent earn-out(9,398)— (9,398)
Unrealized loss on foreign currency4,036 — 4,036 
Loss on disposal of assets— 
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable(44,477)— (44,477)
Inventories(41,431)— (41,431)
Income tax receivable(24,778)14,167 (10,611)
Prepaid expenses and other current assets7,301 — 7,301 
Accounts payable15,834 — 15,834 
Deferred revenue4,991 — 4,991 
Accrued expenses and other current liabilities2,789 — 2,789 
Founders advisory fees - related party (cash settled)(53,547)— (53,547)
Other liabilities24 — 24 
Net cash used in operating activities(89,351)— (89,351)
Cash flows from investing activities:
Purchase of property and equipment(4,006)— (4,006)
Purchase price adjustment under Business Combination Agreement(1,638)— (1,638)
Net cash used in investing activities(5,644)— (5,644)
Cash flows from financing activities:
Ordinary shares repurchased(5,008)— (5,008)
Proceeds from exercise of warrants529 529 
Net cash used in financing activities(4,479)— (4,479)
Effect of foreign currency on cash and cash equivalents(578)— (578)
Net change in cash and cash equivalents(100,052)— (100,052)
Cash and cash equivalents, beginning of period225,554 — 225,554 
Cash and cash equivalents, end of period$125,502 $— $125,502 
Supplemental disclosures of cash flow information:
Cash paid for interest$17,919 $— $17,919 
Cash paid for income taxes$6,572 $— $6,572 
Non-cash investing and financing activities:
Liability portion of founders advisory fees - related party reclassified to additional paid in capital$13,783 $— $13,783 
The impact of the revision on the Company’s unaudited financial statements for the March 2022 Quarter are presented below (in thousands):
MARCH 2022 QUARTER
March 31, 2022
Condensed Consolidated Balance SheetAs ReportedAdjustmentAs Revised
Income tax receivable$17,935 $(10,182)$7,753 
Total current assets332,225 (10,182)322,043 
Total assets2,523,596 (10,182)2,513,414 
Deferred income taxes304,974 (6,881)298,093 
Total liabilities1,382,313 (6,881)1,375,432 
Additional paid-in capital1,684,071 (761)1,683,310 
Accumulated deficit(699,014)(2,540)(701,554)
Total shareholders’ equity 1,141,283 (3,301)1,137,982 
Total liabilities and shareholders’ equity 2,523,596 (10,182)2,513,414 

Condensed Consolidated Statement of Operations and Comprehensive Income (Loss)Three Months Ended March 31, 2022
As ReportedAdjustmentAs Revised
Cost of goods sold$44,627 $(3,284)$41,343 
Gross profit13,131 3,284 16,415 
Selling, general and administrative expense19,808 (654)19,154 
Total operating expenses(25,989)(654)(26,643)
Operating income39,120 3,938 43,058 
Income before income taxes27,579 3,938 31,517 
Income tax benefit (expense)10,232 (4,786)5,446 
Net income (loss)37,811 (848)36,963 
Total comprehensive income (loss)37,937 (848)37,089 
Earnings per share:
Basic$0.24 $(0.01)$0.23 
Diluted$0.22 $(0.01)$0.21 
Three Months Ended March 31, 2022
Condensed Consolidated Statement of Shareholders’ EquityAdditional
Paid-in Capital
Accumulated DeficitTotal Shareholders’ Equity
Balance, December 31, 2021, as reported$1,670,033 $(736,825)$1,083,310 
Adjustments— (1,692)(1,692)
Balance, December 31, 2021, as revised1,670,033 (738,517)1,081,618 
Share-based compensation, as reported$5,724 $— $5,724 
Adjustments(761)— (761)
Share-based compensation, as revised4,963 — 4,963 
Net income, as reported$— $37,811 $37,811 
Adjustments— (848)(848)
Net income, as revised— 36,963 36,963 
Balance, March 31, 2022, as reported$1,684,071 $(699,014)$1,141,283 
Adjustments(761)(2,540)(3,301)
Balance, March 31, 2022, as revised1,683,310 (701,554)1,137,982 
Condensed Consolidated Statement of Cash FlowsThree Months Ended March 31, 2022
As ReportedAdjustmentAs Revised
Cash flow from operating activities:
Net income (loss)$37,811 $(848)$36,963 
Adjustments to reconcile net income to net cash used in operating activities:
Share-based compensation$5,724 $(761)$4,963 
Deferred income taxes6,239 (5,396)843 
Amortization of acquisition related inventory step-up9,299 (3,177)6,122 
Changes in operating assets and liabilities, net of acquisitions:
Income tax receivable$(16,150)$10,182 $(5,968)
The impact of the revision on the Company’s audited financial statements for the December 2021 Period are presented below (in thousands):
DECEMBER 2021 PERIOD
December 31, 2021
Consolidated Balance SheetAs ReportedAdjustmentAs Revised
Inventories$110,087 $(3,177)$106,910 
Total current assets374,937 (3,177)371,760 
Total assets2,581,560 (3,177)2,578,383 
Deferred income taxes298,633 (1,485)297,148 
Total liabilities1,498,250 (1,485)1,496,765 
Accumulated deficit(736,825)(1,692)(738,517)
Total shareholders’ equity 1,083,310 (1,692)1,081,618 
Total liabilities and shareholders’ equity 2,581,560 (3,177)2,578,383 

Consolidated Statement of Operations and Comprehensive Income (Loss)November 9, 2021 Through December 31, 2021
As ReportedAdjustmentAs Revised
Cost of goods sold$20,533 $3,177 $23,710 
Gross profit490 (3,177)(2,687)
Operating loss(677,578)(3,177)(680,755)
Loss before income taxes(685,132)(3,177)(688,309)
Income tax benefit4,675 1,485 6,160 
Net loss(680,457)(1,692)(682,149)
Total comprehensive loss(687,592)(1,692)(689,284)
Net loss per share:
Basic and diluted$(4.33)$(0.01)$(4.34)

November 9, 2021
Through December 31, 2021
Consolidated Statement of Shareholders’ EquityAccumulated DeficitTotal Shareholders’ Equity
Net loss, as reported$(680,457)$(680,457)
Adjustments(1,692)(1,692)
Net loss, as revised$(682,149)$(682,149)
Balance, December 31, 2021, as reported$(736,825)$1,083,310 
Adjustments(1,692)(1,692)
Balance, December 31, 2021, as revised$(738,517)$1,081,618 
Consolidated Statement of Cash FlowsNovember 9, 2021 Through December 31, 2021
As ReportedAdjustmentAs Revised
Cash flow from operating activities:
Net loss$(680,457)$(1,692)$(682,149)
Adjustments to reconcile net loss to net cash provided by operating activities:
Deferred income taxes(670)(1,485)(2,155)
Amortization of acquisition related inventory step-up2,948 3,177 6,125